|
Christine,
I wonder if the overpowered clinical trial you mention was not a deliberate attempt by the manufacturer of the drug to "clean up" the available pool of available volonteering patients with the aim of depriving a competitor of patients to test its drug. This is apparently a common practice among giant pharmaceutical companies according to revelations from a former high level "insider" of the industry.
|